...
【24h】

Industry News

机译:行业新闻

获取原文
获取原文并翻译 | 示例
           

摘要

Camber Pharma Launches Generic of Northern Camber Pharmaceuticals is pleased to announce that it has launched Capsules droxidopa, which is the generic version of Northera (Lundbeck). Droxidopa Capsules are used to treat symptoms of low blood pressure when standing, caused by a certain medical condition, neurogenic orthostatic hypotension. The product is available from Camber in a 300-mg, 90-count bottle. Glenmark Receives FDA Approval forTopiramate, Clindamycin Glenmark Pharmaceuticals Limited has received final approval from the FDA for topiramate extended-release capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg, the generic version of Qudexy XR Capsules, 25 mg, 50 mg, 100 mg, 150 mg, and 200 mg (Upsher-Smith Laboratories, LLC). Glenmark also received FDA approval for clindamycin phosphate gel USP, 1%, a generic version of Cleocin T Gel 1%, (Pharmacia & Upjohn). WebMD Announces New Effort to Combat Vaccine Misinformation With misinformation continuing to undermine public confidence in the COVID-19 vaccines, WebMD announced that it has launched the WebMD COVID-19 Vaccine Misinformation Center to help combat inaccuracies with facts. The Center will provide reliable vaccine resources and online tools to help consumers make informed decisions, driven by science.
机译:坎伯制药公司推出Northern坎伯制药公司的仿制药公司很高兴地宣布,它已推出droxidopa胶囊,这是Northera(Lundbeck)的仿制药版本。Droxidopa胶囊用于治疗站立时出现的低血压症状,这些症状是由特定的医疗条件、神经源性直立性低血压引起的。该产品可从坎伯获得,装在300毫克、90支的瓶子中。Glenmark获得FDA对托吡酯的批准,克林霉素Glenmark Pharmaceuticals Limited已获得FDA对托吡酯缓释胶囊25 mg、50 mg、100 mg、150 mg和200 mg的最终批准。托吡酯缓释胶囊是Qudexy XR胶囊的仿制药,25 mg、50 mg、100 mg、150 mg和200 mg(Upsher Smith Laboratories,LLC)。Glenmark还获得了FDA批准的克林霉素磷酸凝胶USP,1%,一种通用版的Cleocin T凝胶1%,(Pharmacia&Upjohn)。2019冠状病毒疾病防治中心公布2019冠状病毒疾病信息中心,以打击错误的信息,继续打击公众对CVID-19疫苗的信心,WebMD宣布已启动WebMD COVID-19疫苗误报中心,以帮助对抗事实的不准确。该中心将提供可靠的疫苗资源和在线工具,帮助消费者在科学的推动下做出明智的决定。

著录项

  • 来源
    《U. S. pharmacist》 |2021年第3期|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号